Supernus Pharmaceuticals announced an 18% revenue increase to $226.8 million in Q3 2026, driven by strong sales of its growth products including Qelbree and ONAPGO. The company received orphan-drug exclusivity for ONAPGO and submitted an FDA application for a second supplier. Supernus expects to complete its merger with Indivior Pharmaceuticals on November 2, 2026, aiming to create a leading CNS biopharmaceutical company. The merger is anticipated to generate significant shareholder value and cost synergies.
Supernus Pharmaceuticals Q3 2026 results provide context for readers. For those tracking health sector stocks, 106 of 150 rose and 44 fell on Pluang as of Oct 30, 2026 03:11 WIB. Notable movers include CTXR at USD 0.60 (+10.64%, 100% sell), WGS at USD 71.25 (+10.14%, 100% buy), and BAX at USD 23.43 (-7.97%).
iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...
Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...
Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...
Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...
At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...
